Welcome to the international HTA database

Showing [23369 Records] Selected Records [0 Hits] [Clear]

Year	Source	Title
2014	NIHR Health Technology Assessment programme	Death, Bereavement and randomised controlled trials (BRACELET): a methodological study of policy and practice in neonatal and paediatric intensive care trials
2014	Agenzia nazionale per i servizi sanitari regionali (Agenas)	Implantable cardiac resynchronization therapy and defibrillator (CRT-D) in patients with heart failure. Rapid HTA Report
2014	Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)	[Newborn screening for congenital adrenal hyperplasia. Systematic Review]
2014	HAYES, Inc.	Intra-articular injection of non–cross-linked sodium hyaluronate for treatment of shoulder osteoarthritis
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Capnography and/or oximetry monitoring of patients using patient-controlled intravenous opioids: clinical and cost-effectiveness, safety, and guidelines
2014	Malaysian Health Technology Assessment (MaHTAS)	Screening of pregnant women aged 40 years old and above for cardiac abnormalities using electrocardiography (ECG) to prevent maternal mortality
2014	Andalusian Health Technology Assessment Area (AETSA)	Sacroiliac joint fusion. Open versus minimally invasive surgery.
2014	Agenzia nazionale per i servizi sanitari regionali (Agenas)	Ultrasonic energy devices for surgery
2014	HAYES, Inc.	Ancillary procedures and services for the treatment of gender dysphoria
2014	HAYES, Inc.	Laparoscopic radiofrequency volumetric thermal ablation (Acessa System; Halt Medical Inc.) for treatment of uterine fibroids
2014	Unidad de Evaluacion de Tecnologias Sanitarias (UETS)	[Efficacy and safety laparoscopic hysterectomy and lymphadenectomy in endometrial cancer (update)]
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Periodic dental examinations for oral health: a review of clinical effectiveness, cost effectiveness, and guidelines
2014	National Institute for Health and Care Excellence (NICE)	Fluorouracil chemotherapy: The My5‑FU assay for guiding dose adjustment. NICE diagnostics guidance 16
2014	HAYES, Inc.	Bronchial thermoplasty for treatment of asthma
2014	HAYES, Inc.	LINX reflux management system (Torax Medical Inc.) for treatment of gastroesophageal reflux disease (GERD)
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Dehumidifiers for reduction of humidity in operating rooms: clinical effectiveness and guidelines
2014	National Institute for Health and Care Excellence (NICE)	Detecting, managing and monitoring haemostasis: viscoelastometric point‑of‑care testing (ROTEM, TEG and Sonoclot systems). NICE diagnostics guidance 13
2014	NIHR Health Technology Assessment programme	Use of generic and condition-specific measures of health-related quality of life in NICE decision-making: a systematic review, statistical modelling and survey
2014	HAYES, Inc.	Craniosacral therapy
2014	HAYES, Inc.	Magnetic resonance imaging (MRI) for surveillance for breast cancer recurrence following mastectomy and breast reconstruction
2014	Unidad de Evaluacion de Tecnologias Sanitarias (UETS)	[Usefulness of magnetic resonance imaging for the diagnosis of non-specific low back pain]
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Personal wireless device use for wound care consultation: a review of safety, clinical benefits and guidelines
2014	Institute of Health Economics (IHE)	Low dose computed tomography for the screening of lung cancer in adults
2014	National Institute for Health and Care Excellence (NICE)	Measuring fractional exhaled nitric oxide concentration in asthma: NIOX MINO, NIOX VERO and NObreath. NICE diagnostics guidance 12
2014	NIHR Health Technology Assessment programme	The clinical effectiveness, cost-effectiveness and acceptability of community-based interventions aimed at improving or maintaining quality of life in children of parents with serious mental illness: a systematic review
2014	Health Council of the Netherlands Gezondheidsraad (GR)	[Towards a sustainable tissue supply chain]
2014	HAYES, Inc.	Dynamic magnetic resonance imaging for pelvic floor disorders
2014	HAYES, Inc.	Percutaneous sacroplasty for treatment of sacral insufficiency fractures
2014	Unidad de Evaluacion de Tecnologias Sanitarias (UETS)	[Evaluation of efficiency of organizational models for stroke management (stroke units)]
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	High-fidelity simulation training for health care professionals: cost effectiveness and guidelines
2014	Institute of Health Economics (IHE)	First and second trimester prenatal screening update
2014	Malaysian Health Technology Assessment (MaHTAS)	OncoE6TM cervical screening test kit
2014	Scottish Health Technologies Group (SHTG)	In the context of hypothyroidism, what is the evidence for the effectiveness of diagnostic tests and thyroid hormone replacement therapies?
2014	Health Council of the Netherlands Gezondheidsraad (GR)	Incidental findings made during diagnosis in patient care
2014	HAYES, Inc.	Hormone therapy for the treatment of gender dysphoria
2014	HAYES, Inc.	Probe-based confocal laser endomicroscopy (Cellvizio; Mauna Kea Technologies) for surveillance in patients with Barrett's esophagus
2014	Unidad de Evaluacion de Tecnologias Sanitarias (UETS)	[Surgery guided by imaging assessment: efficacy, safety and economic impact of intraoperative magnetic resonance imaging (update)]
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Mattresses for chronic back or neck pain: a review of the clinical effectiveness and guidelines
2014	Institute of Health Economics (IHE)	Endovenous ablation interventions for symptomatic varicose veins of the legs
2014	Technology Assessment at SickKids (TASK)	The cost-effectiveness of clinic-based chloral hydrate sedation versus general anaesthesia for paediatric ophthalmological procedures
2014	HAYES, Inc.	Human acellular dermal matrix grafts for breast reconstruction
2014	HAYES, Inc.	SoundBite hearing system (Sonitus Medical Inc.) for treatment of unilateral hearing loss
2014	Unidad de Evaluacion de Tecnologias Sanitarias (UETS)	[Economic evaluation of preimplantation genetic diagnosis (PGD) for screening]
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Appropriate use of hand-held wireless devices in healthcare settings: guidelines
2014	Institute of Health Economics (IHE)	Hysteroscopic tubal sterilization
2014	Malaysian Health Technology Assessment (MaHTAS)	Infrared regulation thermography for cancer
2014	Adelaide Health Technology Assessment (AHTA)	Intensive upper limb stroke rehabilitation
2014	NIHR Health Technology Assessment programme	A randomised controlled trial of the clinical effectiveness and cost-effectiveness of different knee prostheses: the Knee Arthroplasty Trial (KAT)
2014	HAYES, Inc.	Minimally invasive total hip arthroplasty
2014	HAYES, Inc.	Vocal fold steroid injection for treatment of dysphonia
2014	Unidad de Evaluacion de Tecnologias Sanitarias (UETS)	[Assessment of effectiveness and safety of Cyberknife and Gamma knife radiosurgery in intra and extracraneal lesions' treatment (update)]
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Bivalirudin infusion following angioplasty: safety
2014	Malaysian Health Technology Assessment (MaHTAS)	Effect of promoting formula milk for toddler, and pregnant as well as breastfeeding mothers on the breastfeeding practice
2014	Adelaide Health Technology Assessment (AHTA)	Molecular testing for prostate cancer prognosis
2014	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Transcorneal electrical stimulation for retinitis pigmentosa]
2014	NIHR Health Technology Assessment programme	A clinical and economic evaluation of Control of Hyperglycaemia in Paediatric intensive care: the CHiP randomised controlled trial
2014	HAYES, Inc.	Percutaneous cryoablation for the treatment of renal masses
2014	HAYES, Inc.	Xenex PX ultraviolet light disinfection system (Xenex Disinfection Services LLC) for prevention of hospital-acquired infection
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Stepwise approach for the prescription of opiates for non-cancer pain: a review of clinical evidence and guidelines
2014	Adelaide Health Technology Assessment (AHTA)	An assessment of nucleic acid amplification testing for active mycobacterial infection
2014	Malaysian Health Technology Assessment (MaHTAS)	Enercel homeopathic medicine for patient with infectious diseases and motor neuron disease
2014	NIHR Health Technology Assessment programme	Imatinib for the adjuvant treatment of gastrointestinal stromal tumours
2014	HAYES, Inc.	Percutaneous disc decompression for cervical disc herniation
2014	Unidad de Evaluacion de Tecnologias Sanitarias (UETS)	[Cost effectiveness of different types of coronary stents which are used in patients with acute coronary syndrome (ACS)]
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Nebulizers for the methacholine challenge test: diagnostic accuracy and guidelines
2014	Agency for Healthcare Research and Quality (AHRQ)	Primary care screening for abdominal aortic aneurysm: a systematic evidence review for the U.S. preventive services task force
2014	HAYES, Inc.	Quantitative sensory testing for the diagnosis of lower extremity peripheral neuropathy
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Intra-aortic balloon pumps for cardiac conditions: guidelines
2014	Malaysian Health Technology Assessment (MaHTAS)	Cone beam computed tomography
2014	Institut national d'excellence en sante et en services sociaux (INESSS)	[Efficiency of the "housing first" approach for people who are homeless and living with mental illness or with disorders associated to psychoactive substances]
2014	HAYES, Inc.	Recombinant human bone morphogenetic protein (rhBMP) for use in spinal fusion
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Delivery of electroconvulsive therapy in non-hospital settings: a review of the safety and guidelines
2014	New Zealand National Health Committee (NHC)	Varicella and rotovirus vaccination in New Zealand - assessment reports
2014	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Atomoxetine (Strattera®)
2014	HAYES, Inc.	Sex reassignment surgery for the treatment of gender dysphoria
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Personal protection for visitors to patients on airborne precautions: clinical effectiveness and guidelines
2014	Penn Medicine Center for Evidence-based Practice (CEP)	Update: Cognitive and procedural skills of aging physicians
2014	New Zealand National Health Committee (NHC)	Ischaemic heart disease: a pathway to prioritisation
2014	The Swedish Council on Health Technology Assessment (SBU)	[Drug-eluting stents in coronary arteries]
2014	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Abatacept (Orencia®)
2014	HAYES, Inc.	Total hip replacement with hard on hard prostheses
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Sterilization of gauze for surgical procedures: clinical effectiveness, harms, and guidelines
2014	Penn Medicine Center for Evidence-based Practice (CEP)	Rehydration, anti-diarrheal, and anti-emetic therapy for patients with Ebola virus disease
2014	New Zealand National Health Committee (NHC)	Chronic obstructive pulmonary disease: a pathway to prioritisation
2014	NIHR Health Technology Assessment programme	Optimal strategies for identifying kidney disease in diabetes: properties of screening tests, progression of renal dysfunction and impact of treatment -systematic review and modelling of progression and cost-effectiveness
2014	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Linaclotide (Constella®)
2014	HAYES, Inc.	Vagus nerve stimulation for epilepsy
2014	NIHR Health Services and Delivery Research programme	Public involvement in research: assessing impact through a realist evaluation
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Lifestyle prescriptions: a review of the clinical evidence
2014	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Nalmefene (Selincro®)
2014	HAYES, Inc.	Alpha-1 antitrypsin deficiency (AATD)
2014	NIHR Health Services and Delivery Research programme	A systematic review of the effectiveness and cost-effectiveness of peer-based interventions to maintain and improve offender health in prison settings
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Home isolation to prevent tuberculosis transmission: a review of the clinical evidence and guidelines
2014	Malaysian Health Technology Assessment (MaHTAS)	Typhoid carrier test (Typhidot-C)
2014	HAYES, Inc.	Hereditary paraganglioma (PGL)/pheochromocytoma (PCC) syndromes
2014	NIHR Health Services and Delivery Research programme	Targeting the Use of Reminders and Notifications for Uptake by Populations (TURNUP): a systematic review and evidence synthesis
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Equipment required for medication nebulization: safety and guidelines
2014	Penn Medicine Center for Evidence-based Practice (CEP)	Interventions to expedite administration of antibiotics
2014	Malaysian Health Technology Assessment (MaHTAS)	Colorec bowel aid with Hai's Perianal Support (HPS)
2014	HAYES, Inc.	HLA-B testing for guidance of treatment with anticonvulsant drugs